GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » KP Tissue Inc (OTCPK:KPTSF) » Definitions » EBITDA

KPTSF (KP Tissue) EBITDA : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is KP Tissue EBITDA?

KP Tissue's EBITDA for the three months ended in Dec. 2024 was $0.00 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

KP Tissue's EBITDA per Share for the three months ended in Dec. 2024 was $0.00. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


KP Tissue EBITDA Historical Data

The historical data trend for KP Tissue's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KP Tissue EBITDA Chart

KP Tissue Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

KP Tissue Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of KP Tissue's EBITDA

For the Household & Personal Products subindustry, KP Tissue's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KP Tissue's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where KP Tissue's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

KP Tissue's EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

KP Tissue's EBITDA for the quarter that ended in Dec. 2024 is calculated as

EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

KP Tissue  (OTCPK:KPTSF) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


KP Tissue EBITDA Related Terms

Thank you for viewing the detailed overview of KP Tissue's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


KP Tissue Business Description

Traded in Other Exchanges
Address
2 Prologis Boulevard, Suite 500, Mississauga, ON, CAN, L5W 0G8
KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.

KP Tissue Headlines

From GuruFocus

Q2 2021 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2020 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Kruger Products Announces Price Increase in Canada

By GlobeNewswire 07-08-2024

Q4 2024 KP Tissue Inc Earnings Call Transcript

By GuruFocus News 03-06-2025

Q1 2024 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 05-15-2024

Q4 2020 KP Tissue Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024